15 insiders reported 37 Form 4 transactions for Zentalis Pharmaceuticals, Inc. (ZNTL) over the past 18 months (most recent 2026-06-18). Recent activity: Myers Scott Dunseth (Director) Buy 57,100 shares, Walker Luke Nathaniel (Director) Buy 57,100 shares, Johnson David Michael (Director) Buy 57,100 shares, Skvarka Jan (Director) Buy 57,100 shares, Kariuki Enoch (Director) Buy 57,100 shares. Source: SEC Form 4.
| Date | Insider | Title | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-06-18 | Myers Scott Dunseth | Director | Buy | 57,100 | $0 |
| 2026-06-18 | Walker Luke Nathaniel | Director | Buy | 57,100 | $0 |
| 2026-06-18 | Johnson David Michael | Director | Buy | 57,100 | $0 |
| 2026-06-18 | Skvarka Jan | Director | Buy | 57,100 | $0 |
| 2026-06-18 | Kariuki Enoch | Director | Buy | 57,100 | $0 |
| 2026-02-10 | EASTLAND JULIA MARIE | CEO & President | Sell | 7,866 | $19,114 |
| 2026-02-10 | EASTLAND JULIA MARIE | CEO & President | Sell | 889 | $2,125 |
| 2026-02-10 | Vultaggio Vincent | PAO and PFO | Sell | 29,951 | $72,781 |
| 2026-02-10 | Vultaggio Vincent | PAO and PFO | Sell | 3,379 | $8,076 |
| 2026-02-10 | Vultaggio Vincent | PAO and PFO | Sell | 6,894 | $16,683 |
| 2026-02-10 | Bruns Ingmar | Chief Medical Officer | Sell | 2,962 | $7,198 |
| 2026-02-10 | Bruns Ingmar | Chief Medical Officer | Sell | 335 | $801 |
| 2026-02-04 | Vultaggio Vincent | PAO and PFO | Sell | 2,540 | $6,477 |
| 2026-02-04 | Vultaggio Vincent | PAO and PFO | Sell | 556 | $1,401 |
| 2026-01-08 | WALTERS GROUP | Insider | Buy | 6.5M | $7.8M |
| 2026-01-08 | WALTERS WILLIAM THURMAN | Insider | Buy | 6.5M | $7.8M |
| 2026-01-08 | WALTERS SUSAN BERKLEY | Insider | Buy | 6.5M | $7.8M |
| 2025-12-15 | Matrix Capital Management Company, LP | Insider | Sell | 7.5M | $10.0M |
| 2025-12-15 | GOEL DAVID E. | Insider | Sell | 7.5M | $10.0M |
| 2025-06-18 | Walker Luke Nathaniel | Director | Buy | 57,603 | $0 |
| 2025-06-18 | Myers Scott Dunseth | Director | Buy | 57,603 | $0 |
| 2025-06-18 | Skvarka Jan | Director | Buy | 57,603 | $0 |
| 2025-06-18 | Kariuki Enoch | Director | Buy | 57,603 | $0 |
| 2025-06-18 | Johnson David Michael | Director | Buy | 57,603 | $0 |
| 2025-04-30 | Myers Scott Dunseth | Director | Buy | 21,000 | $29,400 |
Source: SEC Form 4 filings · as of 2026-06-18